REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ios Biotechnologies S.A. (Ecuador)

Main Activities: Convention and Visitors Bureaus
Secondary Activities: Sewage Treatment Facilities
Full name: Ios Biotechnologies S.A. Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Ios Biotechnologies S.A. is a company based in Ecuador, with its head office in Quito. It operates in the Convention and Visitors Bureaus sector. The company was established on December 07, 2007. Ios Biotechnologies S.A. currently employs 5 (2024) people. There was a net sales revenue increase of 212.55% reported in Ios Biotechnologies S.A.’s latest financial highlights for 2024. Its’ total assets recorded a negative growth of 14.72%. The net profit margin of Ios Biotechnologies S.A. increased by 169.5% in 2024.

Headquarters
Armando Pesantes Oe9-14, Cotopaxi.. Dpto. 3 Bldg.
Quito; Pichincha;

Contact Details: Purchase the Ios Biotechnologies S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Ios Biotechnologies S.A. report to view the information.
Registered Capital:
Purchase the Ios Biotechnologies S.A. report to view the information.
Financial Auditors:
Purchase the Ios Biotechnologies S.A. report to view the information.
Incorporation Date:
December 07, 2007
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
92.14%
Purchase this report to view the information.
7.86%
Company Performance
Financial values in the chart are available after Ios Biotechnologies S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
212.55%▲
Total operating revenue
212.55%▲
Operating profit (EBIT)
41.53%▲
EBITDA
N/A
Net Profit (Loss) for the Period
41.53%▲
Total Assets
-14.72%▼
Total Equity
-43.43%▼
Operating Profit Margin (ROS)
169.5%▲
Net Profit Margin
169.5%▲
Return on Equity (ROE)
-2.49%▼
Quick Ratio
0.47%▲
Cash Ratio
0.46%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo